Auto-generated from public data. Not the firm's stated position.
E14 Invest appears to focus on early-stage European ventures spanning healthtech and SaaS, with recent portfolio activity suggesting interest in AI-driven applications across diverse verticals including robotics, energy analytics, and digital health. The firm's disclosed check size of €0.1M–€1.5M and concentration on pre-seed and seed rounds indicates a strategy targeting emerging technologies at their earliest funding stages.
Generated 11 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.